Skip to main content


HomePatientsProvidersClients

Specialty Pharmacy Enrollment Forms

PrintPrintEmailEmail

For use within the US

For additional enrollment forms, please contact Sales Support at pghsalessupport@caremark.com.

Condition MS Word Version Adobe PDF Version
Acromegaly MS Word Adobe PDF
Actiq MS Word AdobePDF
Alcohol Dependence MS Word Adobe PDF
Aranesp MS Word AdobePDF
Allergic Asthma MS Word Adobe PDF
CAPS Syndrome MS Word Adobe PDF
Cystic Fibrosis MS Word Adobe PDF
Crohn's Disease MS Word Adobe PDF
Dermatology/Psoriasis MS Word Adobe PDF
Fertility (Mid West) MS Word Adobe PDF
Fertility (National) MS Word Adobe PDF
Forteo MS Word Adobe PDF
Gastroenterology MS Word Adobe PDF
General (Blank) Caremark Specialty Enrollment Form MS Word Adobe PDF
Growth Hormone Disorders MS Word Adobe PDF
Hematopoietics MS Word Adobe PDF
Hemophilia (& Related Bleeding Disorders) MS Word Adobe PDF
Hepatitis C MS Word Adobe PDF
Hepatitis C Stat Medications MS Word Adobe PDF
Hereditary Angioedema MS Word Adobe PDF
HIV MS Word AdobePDF
HIV/Co-Infection MS Word AdobePDF
Immune Disorders (General and IVIG) MS Word Adobe PDF
Lucentis MS Word AdobePDF
Lupus MS Word AdobePDF
Lysosomal Storage Disorders MS Word Adobe PDF
Macugen MS Word Adobe PDF
Macular Degeneration MS Word Adobe PDF
Mirena   Adobe PDF
Multiple Sclerosis MS Word Adobe PDF
Oncology Orals Hematologic Malignancies MS Word Adobe PDF
Oncology Orals Solid Tumors MS Word Adobe PDF
Osteoarthritis MS Word Adobe PDF
Osteoporosis MS Word Adobe PDF
Procrit MS Word Adobe PDF
Pulmonary Arterial Hypertension MS Word Adobe PDF
Respiratory Syncytial Virus (RSV) MS Word Adobe PDF
Rheumatoid Arthritis MS Word Adobe PDF
Rheumatology MS Word Adobe PDF
Rheumatology IV MS Word Adobe PDF
Rheumatology Subcutaneous MS Word Adobe PDF
Soliris MS Word Adobe PDF
Transplant MS Word Adobe PDF

How May We Help You?

Let CVS Caremark Specialty Pharmacy get your patients started on treatment today.

Call CaremarkConnect

Phone: 1-800-237-2767
Fax: 1-800-323-2445

Now Available

Treating SLE: Benlysta® (Human Genome Sciences/ GlaxoSmithKline), was approved by the U.S. Food and Drug Administration (FDA) on March 10, 2011, for the treatment of active, autoantibody-positive systemic lupus erythematosus (SLE). SLE or "lupus" is a chronic autoimmune disease in which the body's own immune system attacks and destroys healthy tissue.

Please contact your CareTeam for more information.

Pharmacy Drug List

CVS Caremark Specialty Pharmacy Drug List

We provide one of the broadest offerings of specialty pharmaceuticals in the industry

View our Drug List ►